The University of Texas, M.D. Anderson Cancer Center — Houston, Texas

The University of Texas, M.D. Anderson Cancer Center is a clinical research site located in Houston, Texas, United States 77020.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

The University of Texas, M.D. Anderson Cancer Center has participated in 5 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia, Mycosis Fungoides, Acute Lymphoblastic Leukemia (ALL).

Sponsors: Novartis Pharmaceuticals, Yaupon Therapeutics, Spectrum Pharmaceuticals, Inc.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Texas, M.D. Anderson Cancer Center?

The University of Texas, M.D. Anderson Cancer Center has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Texas, M.D. Anderson Cancer Center conducted?

The University of Texas, M.D. Anderson Cancer Center has 5 clinical trials on record. Their work covers Acute Myeloid Leukemia, Mycosis Fungoides, Acute Lymphoblastic Leukemia (ALL).

Is The University of Texas, M.D. Anderson Cancer Center accredited by Crixeo Health?

The University of Texas, M.D. Anderson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Texas, M.D. Anderson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.